XSpray Pharma (Sweden) Market Value
| XSPRAY Stock | SEK 41.40 1.10 2.59% |
| Symbol | XSpray |
XSpray Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XSpray Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XSpray Pharma.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in XSpray Pharma on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding XSpray Pharma AB or generate 0.0% return on investment in XSpray Pharma over 180 days. XSpray Pharma is related to or competes with Xbrane Biopharma, Hansa Biopharma, Cantargia, Vicore Pharma, and BioArctic. Xspray Pharma AB engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden More
XSpray Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XSpray Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XSpray Pharma AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 25.5 | |||
| Value At Risk | (3.68) | |||
| Potential Upside | 5.26 |
XSpray Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XSpray Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XSpray Pharma's standard deviation. In reality, there are many statistical measures that can use XSpray Pharma historical prices to predict the future XSpray Pharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | 0.6212 |
XSpray Pharma AB Backtested Returns
XSpray Pharma AB shows Sharpe Ratio of -0.0729, which attests that the company had a -0.0729% return per unit of risk over the last 3 months. XSpray Pharma AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XSpray Pharma's Mean Deviation of 2.2, market risk adjusted performance of 0.6312, and Standard Deviation of 3.34 to validate the risk estimate we provide. The firm maintains a market beta of -0.47, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning XSpray Pharma are expected to decrease at a much lower rate. During the bear market, XSpray Pharma is likely to outperform the market. At this point, XSpray Pharma AB has a negative expected return of -0.24%. Please make sure to check out XSpray Pharma's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if XSpray Pharma AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
XSpray Pharma AB has virtually no predictability. Overlapping area represents the amount of predictability between XSpray Pharma time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XSpray Pharma AB price movement. The serial correlation of 0.09 indicates that less than 9.0% of current XSpray Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 33.14 |
XSpray Pharma AB lagged returns against current returns
Autocorrelation, which is XSpray Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XSpray Pharma's stock expected returns. We can calculate the autocorrelation of XSpray Pharma returns to help us make a trade decision. For example, suppose you find that XSpray Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XSpray Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XSpray Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XSpray Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XSpray Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
XSpray Pharma Lagged Returns
When evaluating XSpray Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XSpray Pharma stock have on its future price. XSpray Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XSpray Pharma autocorrelation shows the relationship between XSpray Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in XSpray Pharma AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in XSpray Stock
XSpray Pharma financial ratios help investors to determine whether XSpray Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XSpray with respect to the benefits of owning XSpray Pharma security.